Lizzy Quinn is a Musculoskeletal Physiotherapist with 20 years experience focusing on people with spinal pain. Australian Health Journal spoke with Lizzy on the complexities of persistent lower back pain in women.
Lower back pain in women in their 30s, 40s, and 50s is complex to treat due to the combination of physical and emotional factors, and health professionals need to stay updated on best practices and science to provide the best recovery platform for patients. These women typically have busy lives, pressures, and expectations.
The Australian Institute of Health and Welfare (AIHW) website states, ‘Mental and behavioural conditions commonly co-occur with musculoskeletal conditions. Compared with people without musculoskeletal conditions, for people aged 45 and over with mental and behavioural conditions were 1.9 times as likely in people with back problems, 1.6 times as likely in people with arthritis and 1.5 times as likely in people with osteoporosis’.
Lizzy believes women with persistent lower back pain need treatment that considers their emotional and physical pain due to the complexity of their lives. Women with lower back pain often try various treatments without realising the impact of their emotional state on their symptoms, making long-term recovery difficult.
Changes in the spine as we age are normal, but the language used in MRI reports can make it concerning for patients, without a healthcare professional providing a through explanation of some of the terms.
Lizzy states, “MRI findings generally provide little information on how to recover from lower back pain, and only a small number of people actually need imaging straight away. For the majority, it won’t change their treatment.”
Getting a lower back MRI may lead to unnecessary worry as normal age-related changes are often misinterpreted as serious issues.
As far as the body is concerned, the brain cannot tell the difference between physical pain and emotional pain, making lower back pain complex to treat.
Lower back pain may be driven by tissue sensitivity and hyper-sensitisation in the brain, rather than just joint issues.
Emotional distress can reactivate sensitisation in the brain, that can cause persistent lower back pain, especially when combined with emotional distress. Sensitised pain centres in the brain, can prolong lower back pain even after physical healing.
Educating patients about the complexity of lower back pain is important, but GPs have limited time to do so, making it challenging for them to convey the message to their clients.
Without this awareness, patients will fail to understand the main drivers of lower back pain that are vital for long term recovery.
-
Lived experience & human-centred design in healthcare
Recognised as one of the Top 100 Women of Influence by The Australian Financial Review, Melanie Tran is a visionary leader whose work lies at the intersection of design, technology, health, disability, and education. With a focus on human-centred design, digital strategy, and service design, she leads transformative initiatives as a Manager in Design, Digital and Data at Nous Group, a global consulting firm. Her work is driven by a deep passion for using creativity and technology to solve complex social challenges.
-
Gold Coast paediatric emergency nurse leads world’s largest study in securement
Brooke Charters is a dynamic Paediatric Emergency Nurse who works at the Gold Coast University Hospital in Queensland. Brooke’s research became the world’s largest study of its kind and in May 2024 the results of the study were published in JAMA Pediatrics. Her mission is to drive change and enhance the hospital experience for children globally.
-
Making clinical trials participant friendly
Clinical trials are essential in developing new, improved, and more effective treatments and interventions. Without trials, researchers and professionals in the field cannot properly determine whether these new treatments and interventions are safe and effective.
The Clinials platform is geared towards patient centric trials and reducing site burden. The aim is to accelerate lifesaving medicines coming to market by connecting participants and researchers. The platform allows participants to come to researchers with their eligibility in hand among other capabilities.
